FDA-Drug2025-12-24Class IIPACKAGING DEFECT

Novocol 2% Xylocaine Dental with Epinephrine recalled for cracked cartridges

GLASSNationwide distributionDrugs

What this means

Novocol Pharmaceutical issued a recall of 2% Xylocaine Dental with Epinephrine 1:100,000 injection cartridges due to defective containers—some cartridges are cracked or broken. This affects lot D05337B (expires 06-30-2027). The problem was discovered during quality control; no injuries have been reported.

  • Check your dental office or clinic supply for lot D05337B cartridges
  • Stop using any cracked or broken cartridges immediately
  • Contact your supplier or Novocol Pharmaceutical for instructions on return or replacement
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Defective container: cracked/broken cartridges

Intended for
Adults
Illnesses reported
None reported
Sold states
U.S.A. Nationwide
Affected count
18,789 cartons- 50 cartridges /carton
Manufactured in
25 Wolseley Crt, Cambridge, Canada
Products
2% Xylocaine DENTAL with Epinephrine 1:100,000 (Lidocaine HCI and Epinephrine Injection USP), packaged in a carton containing 50 single-dose cartridges, 1.7 mL each, Rx only, Manufactured for Dentsply Pharmaceutical, York, PA 17404, by Novocol Pharmaceutical of Canada, Inc., NDC 66312-176-16.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0228-2026

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.